"10.1371_journal.pone.0051139","plos one","2012-12-07T00:00:00Z","Amory Schlender; Peter E Alperin; Helene L Grossman; E Rand Sutherland","Archimedes Incorporated, San Francisco, California, United States of America; Department of Medicine, National Jewish Health, Denver, Colorado, United States of America; Department of Medicine, University of Colorado, Denver, Colorado, United States of America","Conceived and designed the experiments: AS PEA HLG ERS. Performed the experiments: AS PEA HLG. Analyzed the data: AS PEA HLG ERS. Contributed reagents/materials/analysis tools: AS PEA HLG ERS. Wrote the paper: AS ERS PEA HLG.","The authors have read the journalâ€™s policy and have the following conflicts: Dr. Sutherland: Consultant: Forest Laboratories, GlaxoSmithKline, Merck, Novartis, Dey. Grants unrelated to the current study: Boehringer Ingelheim, Novartis. Educational presentation: Genentech. Mr. Schlender, Dr. Alperin and Dr. Grossman are all employees of Archimedes Incorporated. Dr. Sutherland has served as a consultant to Archimedes Incorporated in the past. There are no patents, products in development or marketed products to declare. This does not alter the author's adherence to all the PLOS ONE policies on sharing data and materials.","2012","12","Amory Schlender","AS",4,TRUE,4,3,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
